Inventor

Marta Blumenfeld

Inventor

Paris, FR

Overview

38→

Patents

1999–2018

Patent span

Chemistry

Primary field (CPC C)

Patents· 38 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Qprimary

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms26%

A01KAnimal husbandry15%

A61KPreparations for medical, dental or toiletry purposes13%

C07KPeptides13%

C12NMicroorganisms or enzymes9%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%

C07DHeterocyclic compounds6%

G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology6%

G01NInvestigating or analysing materials by determining their chemical or physical properties3%

Y10TTechnical subjects covered by former us classification2%

PatentTitleYear

9,974,779Piperidine derivatives as human papilloma virus inhibitors2018 9,908,858'Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus'2018 9,670,159'Pharmaceutical composition of a papillomavirus inhibitor'2017 9,452,991'Piperidine derivatives as human papilloma virus inhibitors'2016 8,440,833'Human papilloma virus inhibitors and pharmaceutical compositions containing same'2013 8,207,373'Benzoic acid derivatives as human papilloma virus inhibitors'2012 7,838,241'Genotyping methods using genomic sequence of the 5-lipoxygenase-activating protein (FLAP) and polymorphic markers thereof'2010 7,547,771'Polymorphic markers of prostate carcinoma tumor antigen -1(PCTA-1)'2009 7,494,777'Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma'2009 7,432,056'Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism'2008 7,427,482'Methods of assessing the risk for the development of sporadic prostate cancer'2008 7,371,811'Schizophrenia associated genes, proteins and biallelic markers'2008 7,189,833'Prostate cancer gene'2007 7,125,667'Polymorphic markers of the LSR gene'2006 7,118,869'Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma'2006 7,105,353'Methods of identifying individuals for inclusion in drug studies'2006 7,067,627'Schizophrenia associated genes, proteins and biallelic markers'2006 7,041,454'Genomic sequence of the purH gene and purH-related biallelic markers'2006 7,037,709'Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy'2006 6,825,004'Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof'2004 6,794,143'Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism'2004 6,759,192'Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1)'2004 6,555,316'Schizophrenia associated gene, proteins and biallelic markers'2003 6,551,792'Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy'2003 6,544,737'Genomic sequence of the purH gene and purH-related biallelic markers'2003 6,537,751'Biallelic markers for use in constructing a high density disequilibrium map of the human genome'2003 6,531,279'Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma'2003 6,528,260'Biallelic markers related to genes involved in drug metabolism'2003 6,479,238'Polymorphic markers of the LSR gene'2002 6,476,208'Schizophrenia associated genes, proteins and biallelic markers'2002 6,432,648'Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism'2002 6,369,038'Closed antisense and sense oligonucleotides and their applications'2002 6,346,381'Prostate cancer gene'2002 6,291,182'Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait'2001 6,265,546'Prostate cancer gene'2001 6,228,580'Nucleic acid detection method using nucleotide probes enabling both specific capture and detection'2001 6,187,913'Covalently crosslinked oligonucleotides, preparation method and synthon which is of use in the method'2001 5,945,522'Prostate cancer gene'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2004Patents assigned to GENSET SA (18)· patent assignee history

1999–2018Based in Paris, FR· patent location history

2006–2010Patents assigned to SERONO GENETICS INST SA (13)· patent assignee history

2012–2016Patents assigned to BLUMENFELD MARTA (3)· patent assignee history

2012–2016Patents assigned to COMPERE DELPHINE (3)· patent assignee history

2016–2018Patents assigned to AVIRAGEN THERAPEUTICS INC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
GENSET SA	18	1999–2004
SERONO GENETICS INST SA	13	2006–2010
AVIRAGEN THERAPEUTICS INC	4	2016–2018
BLUMENFELD MARTAself	3	2012–2016
COMPERE DELPHINE	3	2012–2016

Locations

Location	Patents	Span
Paris, FR	38	1999–2018